We're thrilled to introduce Dr. Qian Cheng as the newest member of CURA Diagnostics, joining us as our Chief Scientific Officer. With over a decade of experience in the toxicology field, including eight years as a board-certified Clinical Laboratory Director, Dr. Cheng brings a wealth of expertise. He's highly proficient in handling LC-MS instruments across major vendors like Sciex, Agilent, Thermo, and Shimadzu, showcasing adeptness in LC-MS analytical method development and validation.

Dr. Cheng's role at CURA Diagnostics Inc. holds immense importance, overseeing our R&D endeavors for innovative in-vitro diagnostics and steering our lab services. His long-standing goal has been to enhance the robustness and accessibility of lab tests for patients. His prior expertise primarily centered on LC-MS applications within clinical laboratories. While establishing an LC-MS lab is complex, Dr. Cheng's notable success lies in sourcing, training, and retaining the right personnel, an aspect CURA is passionate about.

Having supported labs of all sizes, particularly small and physician office labs, Dr. Cheng has excelled even with limited resources. His efforts have resulted in significantly faster turnaround times for toxicology tests and the implementation of customer test protocols aimed at better monitoring patient compliance.

We're incredibly excited to have Dr. Cheng on board and anticipate more thrilling updates in the months ahead. Stay tuned for further information and updates!